European Biotech Acquisition Corp. (EBAC)

NASDAQ: EBAC · IEX Real-Time Price · USD
0.00 (0.00%)
Jan 31, 2023, 4:00 PM EST - Market closed
Market Cap 166.45M
Revenue (ttm) n/a
Net Income (ttm) 860,478
Shares Out 16.40M
EPS (ttm) 0.04
PE Ratio 253.75
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 518,532
Open 10.65
Previous Close 10.15
Day's Range 10.15 - 10.65
52-Week Range 9.66 - 10.60
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About EBAC

European Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. European Biotech Acquisition Corp. was incorporated in 2021 and is based in Amsterdam, the Netherlands. [Read more]

Industry Shell Companies
Sector Financials
IPO Date Mar 16, 2021
Country Netherlands
Stock Exchange NASDAQ
Ticker Symbol EBAC
Full Company Profile

Financial Performance

Financial Statements


European Biotech Acquisition Corp. Receives Expected Notification from Nasdaq Related to Delayed Quarterly Report

NEW YORK--(BUSINESS WIRE)--European Biotech Acquisition Corp. receives expected notification from Nasdaq related to delayed quarterly report.

1 year ago - Business Wire